The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Open accessAbstract
BACKGROUND. NAFLD ranges from simple steatosis (SS) to non-alcoholic steatohepatitis (NASH). The natural history of NAFLD and the optimal strategy to identify subjects with progressive liver disease are unclear. Objectives. To assess the evidence in: (1) natural history of NAFLD; and (2) non-invasive methods to differentiate NAFLD histological subtypes. DESIGN AND SETTING. Among 4185 articles published on MEDLINE, Cochrane Library, EMBASE, Pubmed, national and International meeting abstracts through July 2010, 40 articles assessing the natural history of NAFLD and 32 articles evaluating the diagnostic accuracy of non-invasive tests against liver biopsy (LB) were included. MEASUREMENTS. Two reviewers retrieved articles and evaluated study quality by appropriate scores. Main outcomes were pooled using random- or fixed-effects models. RESULTS. NAFLD has an increased overall mortality (OR: 1.57, 95% CI: 1.18-2.10), deriving from liver-related and cardiovascular disease, and a 2-fold risk of diabetes. Compared to SS, NASH has a higher liver-related (OR for NASH: 5.71, 2.31-14.13; OR for NASH with advanced fibrosis: 10.06, 4.35-23.25), but not cardiovascular mortality (OR: 0.91, 0.42-1.98). Three non-invasive methods received independent validation: pooled AUROC, sensitivity and specificity of cytokeratin-18 for NASH are 0.82 (0.78-0.88), 0.78 (0.64-0.92), 0.87 (0.77-0.98). For NASH with advanced fibrosis, pooled AUROC, sensitivity and specificity of NAFLD fibrosis score and Fibroscan are 0.85 (0.80-0.93), 0.90 (0.82-0.99), 0.97 (0.94-0.99) and 0.94 (0.90-0.99), 0.94 (0.88-0.99) and 0.95 (0.89-0.99). CONCLUSIONS. NAFLD warrants screening for cardio-metabolic risk and for progressive liver disease. The combination of three noninvasive tests with LB may optimally individuate patients with NASH, with or without advanced fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010 · Cited by 17,796
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., de Vet, H. C. W., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00010 · Cited by 3,219
Angulo, P., Hui, J. M., Marchesini, G., Bugianesi, E., George, J., Farrell, G. C., Enders, F., Saksena, S., Burt, A. D., Bida, J. P., et al. (2007) · Hepatology · doi:10.1002/hep.21496 · Cited by 3,203
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Stein, J. H., Korcarz, C. E., Hurst, R. T., Lonn, E., Kendall, C. B., Mohler, E. R., Najjar, S. S., Rembold, C. M., & Post, W. S. (2008) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.11.011 · Cited by 2,429
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
(2012) · Hepatogastroenterology · doi:10.5754/hge11893 · Cited by 1,338
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations
Castéra, L., Foucher, J., Bernard, P.-H., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., & de Lédinghen, V. (2010) · Hepatology · doi:10.1002/hep.23425 · Cited by 1,159
Systematic Reviews of Diagnostic Test Accuracy
Leeflang, M. M. G., Deeks, J. J., Gatsonis, C., & Bossuyt, P. M. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-12-200812160-00008 · Cited by 1,124
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S., & Neuschwander-Tetri, B. A. (2008) · Gut · doi:10.1136/gut.2007.146019 · Cited by 869
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Guha, I. N., Parkes, J., Roderick, P., Chattopadhyay, D., Cross, R., Harris, S., Kaye, P., Burt, A. D., Ryder, S. D., Aithal, G. P., et al. (2008) · Hepatology · doi:10.1002/hep.21984 · Cited by 745
Long-Term Follow-Up of Patients With Nonalcoholic Fatty Liver
Rafiq, N., Bai, C., Fang, Y., Srishord, M., McCullough, A., Gramlich, T., & Younossi, Z. M. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.11.005 · Cited by 729
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717
Feldstein, A. E., Wieckowska, A., Lopez, R. A., Liu, Y.-C., Zein, N. N., & McCullough, A. J. (2009) · Hepatology · doi:10.1002/hep.23050 · Cited by 712
Fracanzani, A. L., Valenti, L., Bugianesi, E., Andreoletti, M., Colli, A., Vanni, E., Bertelli, C., Fatta, E., Bignamini, D., Marchesini, G., et al. (2008) · Hepatology · doi:10.1002/hep.22429 · Cited by 711
Wieckowska, A., Zein, N. N., Yerian, L. M., Lopez, R. A., McCullough, A. J., & Feldstein, A. E. (2006) · Hepatology · doi:10.1002/hep.21223 · Cited by 670
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.018 · Cited by 638
Targher, G., Bertolini, L., Rodella, S., Tessari, R., Zenari, L., Lippi, G., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc07-0349 · Cited by 579
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 574
Ruttmann, E., Brant, L. J., Concin, H., Diem, G., Rapp, K., Ulmer, H., & the Vorarlberg Health Monitoring and Promotion Program Study Group (2005) · Circulation · doi:10.1161/circulationaha.105.552547 · Cited by 556
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552
Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease
Hamaguchi, M. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i10.1579 · Cited by 542
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Sanyal, A. J., Banas, C., Sargeant, C., Luketic, V. A., Sterling, R. K., Stravitz, R. T., Shiffman, M. L., Heuman, D., Coterrell, A., Fisher, R. A., et al. (2006) · Hepatology · doi:10.1002/hep.21103 · Cited by 522
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam-Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 508
Ratziu, V., Massard, J., Charlotte, F., Messous, D., Imbert-Bismut, F., Bonyhay, L., Tahiri, M., Munteanu, M., Thabut, D., Cadranel, J. F., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-6 · Cited by 492
Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 483
Nobili, V., Vizzutti, F., Arena, U., Abraldes, J. G., Marra, F., Pietrobattista, A., Fruhwirth, R., Marcellini, M., & Pinzani, M. (2008) · Hepatology · doi:10.1002/hep.22376 · Cited by 430
Yoneda, M., Yoneda, M., Mawatari, H., Fujita, K., Endo, H., Iida, H., Nozaki, Y., Yonemitsu, K., Higurashi, T., Takahashi, H., et al. (2008) · Digestive and Liver Disease · doi:10.1016/j.dld.2007.10.019 · Cited by 428
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420
Adams, L. A., Waters, O. R., Knuiman, M. W., Elliott, R. R., & Olynyk, J. K. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.67 · Cited by 413
Sookoian, S., & Pirola, C. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.06.012 · Cited by 406
Elevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Alanine Aminotransferase, γ-Glutamyltransferase, and Incident Diabetes
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Davey Smith, G., & Lawlor, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-1870 · Cited by 385
Sattar, N., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Stanley, A., Forrest, E., MacFarlane, P. W., Packard, C. J., Cobbe, S. M., & Shepherd, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2855 · Cited by 375
Nonalcoholic fatty liver disease: A review of current understanding and future impact
Charlton, M. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00440-9 · Cited by 350
Gamma-glutamyltransferase and diabetes—a 4 year follow-up study
Lee, D.-H., Ha, M.-H., Kim, J.-H., Christiani, D. C., Gross, M. D., Steffes, M., Blomhoff, R., & Jacobs, D. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1036-5 · Cited by 344
Poynard, T., Munteanu, M., Imbert-Bismut, F., Charlotte, F., Thabut, D., Le Calvez, S., Messous, D., Thibault, V., Benhamou, Y., Moussalli, J., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.032227 · Cited by 343
Wannamethee, G., Ebrahim, S., & Gerald Shaper, A. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117699 · Cited by 334
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.018 · Cited by 330
Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort Study
Dunn, W., Xu, R., Wingard, D. L., Rogers, C., Angulo, P., Younossi, Z. M., & Schwimmer, J. B. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02034.x · Cited by 325
Liver Enzymes, the Metabolic Syndrome, and Incident Diabetes
Nannipieri, M., Gonzales, C., Baldi, S., Posadas, R., Williams, K., Haffner, S. M., Stern, M. P., & Ferrannini, E. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1757 · Cited by 308
Nakanishi, N., Suzuki, K., & Tatara, K. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1427 · Cited by 304
the LIDO Study Group and the CYTOL study group, Poynard, T., Ratziu, V., Charlotte, F., Messous, D., Munteanu, M., Imbert-Bismut, F., Massard, J., Bonyhay, L., Tahiri, M., et al. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-34 · Cited by 302
Adams, L. A., Harmsen, S., St. Sauver, J. L., Charatcharoenwitthaya, P., Enders, F. B., Therneau, T., & Angulo, P. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.18 · Cited by 293
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
Younossi, Z. M., Jarrar, M., Nugent, C., Randhawa, M., Afendy, M., Stepanova, M., Rafiq, N., Goodman, Z., Chandhoke, V., & Baranova, A. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9506-y · Cited by 277
Fraser, A., Harris, R., Sattar, N., Ebrahim, S., Smith, G. D., & Lawlor, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.152298 · Cited by 277
Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2913 · Cited by 274
Nobili, V., Parkes, J., Bottazzo, G., Marcellini, M., Cross, R., Newman, D., Vizzutti, F., Pinzani, M., & Rosenberg, W. M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.013 · Cited by 265
Comparison of blood tests for liver fibrosis specific or not to NAFLD
Calès, P., Lainé, F., Boursier, J., Deugnier, Y., Moal, V., Oberti, F., Hunault, G., Rousselet, M. C., Hubert, I., Laafi, J., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.035 · Cited by 260
Haring, R., Wallaschofski, H., Nauck, M., Dörr, M., Baumeister, S. E., & Völzke, H. (2009) · Hepatology · doi:10.1002/hep.23135 · Cited by 245
Nonalcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-Aged Japanese Men
Shibata, M., Kihara, Y., Taguchi, M., Tashiro, M., & Otsuki, M. (2007) · Diabetes Care · doi:10.2337/dc07-0792 · Cited by 238
Ngo, Y., Munteanu, M., Messous, D., Charlotte, F., Imbert-Bismut, F., Thabut, D., Lebray, P., Thibault, V., Benhamou, Y., Moussalli, J., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.070961 · Cited by 229
Lee, D.-H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl086 · Cited by 224
Baumeister, S. E., Völzke, H., Marschall, P., John, U., Schmidt, C., Flessa, S., & Alte, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.10.024 · Cited by 208
Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD), Sumida, Y., Yoneda, M., Hyogo, H., Yamaguchi, K., Ono, M., Fujii, H., Eguchi, Y., Suzuki, Y., Imai, S., et al. (2011) · Journal of Gastroenterology · doi:10.1007/s00535-010-0305-6 · Cited by 199
Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
Mayo, M. J., Parkes, J., Adams-Huet, B., Combes, B., Mills, A. S., Markin, R. S., Rubin, R., Wheeler, D., Contos, M., West, A. B., et al. (2008) · Hepatology · doi:10.1002/hep.22517 · Cited by 198
Ebrahim, S., Sung, J., Song, Y.-M., Ferrer, R. L., Lawlor, D. A., & Smith, G. D. (2006) · BMJ · doi:10.1136/bmj.38855.610324.80 · Cited by 189
A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients
Campos, G. M., Bambha, K., Vittinghoff, E., Rabl, C., Posselt, A. M., Ciovica, R., Tiwari, U., Ferrel, L., Pabst, M., Bass, N. M., et al. (2008) · Hepatology · doi:10.1002/hep.22241 · Cited by 172
Yilmaz, Y. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i6.837 · Cited by 168
Diab, D. L., Yerian, L., Schauer, P., Kashyap, S. R., Lopez, R., Hazen, S. L., & Feldstein, A. E. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.07.016 · Cited by 168
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
Jepsen, P., Vilstrup, H., Mellemkjær, L., Thulstrup, A. M., Olsen, J. H., Baron, J. A., & Sørensen, H. T. (2003) · PubMed · Cited by 152
Abnormal Liver Function Test Predicts Type 2 Diabetes
Cho, N. H., Jang, H. C., Choi, S. H., Kim, H. R., Lee, H. K., Chan, J. C. N., & Lim, S. K. (2007) · Diabetes Care · doi:10.2337/dc07-0106 · Cited by 152
Monami, M., Bardini, G., Lamanna, C., Pala, L., Cresci, B., Francesconi, P., Buiatti, E., Rotella, C. M., & Mannucci, E. (2008) · Metabolism · doi:10.1016/j.metabol.2007.10.015 · Cited by 148
Liver Enzymes as a Predictor for Incident Diabetes in a Japanese Population: The Hisayama Study
Doi, Y., Kubo, M., Yonemoto, K., Ninomiya, T., Iwase, M., Tanizaki, Y., Shikata, K., Iida, M., & Kiyohara, Y. (2007) · Obesity · doi:10.1038/oby.2007.218 · Cited by 144
Meisinger, C., Döring, A., Schneider, A. L. C., & Löwel, H. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.01.010 · Cited by 135
Wong, V. W., Wong, G. L., Chim, A. M., Tse, A. M. L., Tsang, S. W., Hui, A., Choi, P. C., Chan, A. W. H., So, W., Chan, F. K. L., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01933.x · Cited by 126
Ruffillo, G., Fassio, E., Álvarez, E., Landeira, G., Longo, C., Domínguez, N., & Gualano, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.028 · Cited by 126
Ong, J. P., Pitts, A., & Younossi, Z. M. (2008) · Journal of Hepatology · doi:10.1016/s0168-8278(08)60008-2 · Cited by 119
Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults
Kim, C., Park, J.-Y., Lee, K.-U., Kim, J. H., & Kim, H. ‐. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02410.x · Cited by 118
Meisinger, C., Löwel, H., Heier, M., Schneider, A. L. C., Thorand, B., & FOR THE KORA STUDY GROUP (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01572.x · Cited by 110
Ryan, M. C., Wilson, A., Slavin, J., Best, J. D., Jenkins, A. J., & Desmond, P. V. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1222 · Cited by 100
Liver Enzymes and Incident Diabetes
Ford, E. S., Schulze, M. B., Bergmann, M. M., Thamer, C., Joost, H., & Boeing, H. (2008) · Diabetes Care · doi:10.2337/dc07-2159 · Cited by 97
Wong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 96
André, P., Balkau, B., Born, C., Royer, B., Wilpart, E., Charles, M.-A. A., & Eschwège, É. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70229-x · Cited by 93
Haukeland, J. W., Konopski, Z., Linnestad, P., Azimy, S., Løberg, E. M., Haaland, T., Birkeland, K. I., & Bjøro, K. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500264953 · Cited by 90
Computer assisted quantitation of terminal hepatic vein connective tissue in the rat
Keegan, A. D., & Batey, R. G. (1992) · Pathology · doi:10.3109/00313029209068881 · Cited by 90
Kim, C., Park, J., Lee, K., Kim, J.-H., & Kim, H. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.890 · Cited by 89
Obara, N., Ueno, Y., Fukushima, K., Nakagome, Y., Kakazu, E., Kimura, O. S., Wakui, Y., Kido, O., Ninomiya, M., Kogure, T., et al. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2225-2 · Cited by 87
Arun, J. S., Jhala, N., Lazenby, A. J., Clements, R. H., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9041-2 · Cited by 87
Malik, R., Chang, M., Bhaskar, K. R., Nasser, I. A., Curry, M. P., Schuppan, D., Byrnes, V., & Afdhal, N. H. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05731.x · Cited by 87
Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes
Satō, K., Hayashi, T., Nakamura, Y., Harita, N., Yoneda, T., Endo, G., & Kambe, H. (2008) · Diabetes Care · doi:10.2337/dc07-2184 · Cited by 78
Chang, J. P.-E., Lui, H. F., Chau, Y. P., Lim, K. H., Yap, W. M. Q., Tan, C., & Chow, W. C. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03711.x · Cited by 72
The Utility of the “NAFLD Fibrosis Score” in Morbidly Obese Subjects with NAFLD
Qureshi, K., Clements, R. H., & Abrams, G. A. (2008) · Obesity Surgery · doi:10.1007/s11695-007-9295-8 · Cited by 66
Raszeja‐Wyszomirska, J., Szymanik, B., Ławniczak, M., Kajor, M., Chwist, A., Milkiewicz, P., & Hartleb, M. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-67 · Cited by 64
γ-Glutamyltransferase predicts cardiovascular death among Japanese women
Hozawa, A., Okamura, T., Kadowaki, T., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.058 · Cited by 56
The Association of Fatty Liver and Diabetes Risk.
Okamoto, M., Takeda, Y., Yoda, Y., Kobayashi, K., Fujino, M., & Yamagata, Z. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.15 · Cited by 54
Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease
Yun, J. W., Cho, Y. K., Park, J. H., Kim, H. J., Park, D. I., Sohn, C. I., Jeon, W. K., & Kim, B. I. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01920.x · Cited by 51
Olynyk, J. K., Knuiman, M. W., Divitini, M., Davis, T. M. E., Beilby, J. P., & Hung, J. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.229 · Cited by 49
Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance
Sargın, M., li, O. U. B., Sargın, H., Orbay, E., & Yayla, A. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200311000-00010 · Cited by 46
Musso, G., Gambino, R., Durazzo, M., & Cassader, M. (2009) · Hepatology · doi:10.1002/hep.23255 · Cited by 37
Self-citationSchindhelm, R. K., Dekker, J. M., Nijpels, G., Heine, R. J., & Diamant, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2812 · Cited by 35
Su, C., Wang, K., Hsia, T., Chen, C.-S., & Tung, T. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200607000-00015 · Cited by 26
Pimentel, S. K., Strobel, R., Gonçalves, C. G., Sakamoto, D. G., Ivano, F. H., & Coelho, J. C. U. (2010) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032010000200010 · Cited by 26
Jiamjarasrangsi, W., Sangwatanaroj, S., Lohsoonthorn, V., & Lertmaharit, S. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.01.009 · Cited by 25
de Lédinghen, V., Fournier, C., Foucher, J., Miette, V., Vergniol, J., Rigalleau, V., Merrouche, W., & Sandrin, L. (2009) · Journal of Hepatology · doi:10.1016/s0168-8278(09)60991-0 · Cited by 15
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Metadata
- Authors
- Musso, G., Gambino, R., Cassader, M., & Pagano, G.
- Venue
- Annals of Medicine
- Publisher
- Informa UK Limited
- Published
- 2010-11-02
- Volume
- 43
- Issue
- 8
- Pages
- 617-649
- ISSN
- 0785-3890 (ISSN-L)
- 1365-2060
- OpenAlex
- W2025106732
- Cited by
- 1,293
- References
- 113
- FWCI
- 33.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.